ISMRM20 Educational: MRI in Cardio-Oncology

Educational Course

MRI in Cardio-Oncology

Back to Program-at-a-Glance

Session Topic: Novel clinical applications of CMR

Session Sub-Topic: MRI in Cardio-Oncology

Weekday Course

ORGANIZERS: Aleksandra Radjenovic, Tim Leiner

Thursday Parallel 3 Live Q&A

Thursday, 13 August 2020, 15:05 - 15:50 UTC

Moderators: Michael Salerno & Yuchi Liu

Skill Level: Basic to Advanced

Session Number: Th-02

Overview
Cardio-oncology is a new cardiology sub-specialty focused on early detection of cardiovascular complications of cancer treatments with the aim of improving early detection of treatment-induced cardiovascular complications as well as their prevention and treatment. Current state of cardio-oncology in different regions will be discussed (including guidelines and training schemes), as well as the activities of international organizations.

MRI has emerged as a promising tool for the assessment of treatment-induced changes in cardiac morphology, tissue composition, and function. This course will highlight the current role of MRI in cardio-oncology and outline the potential of further developments in this area, aimed at reducing the increasing burden of cardiovascular complications in patients receiving cancer therapies.

Target Audience
Basic scientists and clinicians interested in MRI methods that can explore and assess the effects of oncological treatments on cardiovascular morphology, tissue composition, and function.

Educational Objectives
As a result of attending this course, participants should be able to:
- Explain the scope of the new cardiac sub-specialty of cardio-oncology and current clinical practice of this emerging discipline in different countries;
- Define the current role of MRI in cardio-oncology;
- Predict future opportunities for the development of MRI tools for elucidating the mechanisms of cardio-toxicity of cancer treatments; and
- Evaluate the potential of MRI as a tool for improving identification and prevention of short and long-term cardiovascular complications in patients receiving cancer therapies.

		Introduction to Cardio-Oncology Mark Nolan Watch the Video Cardio-Oncology is a new and rapidly expanding clinical field that challenges traditional treatment paradigms in helping a vulnerable population. Cardiovascular complications of novel chemotherapeutics are increasingly recognized and can affect nearly any dimension of cardiac function. Therefore there is a need for versatile cardiac imaging techniques which can guide physicians be looking beyond traditional imaging biomarkers, such as LVEF. Cardiovascular MRI is well-positioned to meet these challenges. This session will introduce the current landscape of cardio-oncology and how cardiovascular MRI may help.
		Emerging Clinical Practice of Cardio-Oncology Lauren Baldassarre Watch the Video
		Current Role of MRI in Cardio-Oncology Bernd Wintersperger Watch the Video Related to the continuously improved patient long term survival and improved personalized cancer therapy regimens, adverse cardiovascular effects of cancer therapy have become highly important considerations. Given its accuracy and precision as well its ability to assess details of the myocardial tissue characterization makes cardiac MRI a prime modality in assessment of potential cancer therapy related cardiac dysfunction (CTRCD) as well as tissue changes.
		What Can MRI Bring to the Field of Cardio-Oncology in the Future? Yoo Jin Hong Video Permission Withheld Current guidelines consider LVEF assessment using echocardiography as the standard diagnostic technique for detecting chemotherapy-induced cardiotoxicity. However, magnetic resonance imaging (MRI) may play an important role in the cardiac evaluation of cancer patients.